Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
about
Histone demethylase lysine demethylase 5B in development and cancermiR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells.KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer.Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes.Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck.Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.SuperQuant-assisted comparative proteome analysis of glioblastoma subpopulations allows for identification of potential novel therapeutic targets and cell markers.Downregulation of microRNA-448 inhibits IL-1β-induced cartilage degradation in human chondrocytes via upregulation of matrilin-3.Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB.MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasisHistone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictorResearch progresses in roles of LncRNA and its relationships with breast cancer
P2860
Q28076257-C5263C58-A69A-48CB-80AC-0F301B600806Q37144049-D955F7C9-BB79-4177-B608-E93FEABA07A7Q37391872-39B31BD8-A387-4E3A-A400-D9E69638DBE0Q37437363-490DAF0E-5246-4BA5-9381-F097640D3BE7Q37688468-5E9B72B9-18FA-487A-9590-AD28D0D16D34Q37697223-72608472-E20C-4AD8-AC4C-B8957D984EBFQ41093581-B97C4F49-ACEB-464E-96D7-B865A5A60542Q47097815-F242BA43-AD88-4749-BC4D-3817C30E9619Q47164659-9AE69A40-237F-4C1F-9445-59FBE5A216B6Q52672948-B5F4C11A-DC37-42D2-99F3-84260F45CF62Q52684219-7412A340-3AA5-4E74-A95D-26C44ACDD85AQ54858561-D8701740-7109-4581-A615-1595521FE354Q55245371-29B05FB3-DBF6-4B4F-837C-E52B69A0BE3AQ55438036-E32FE8E6-5F4F-477A-AC8B-5E865E457AB3Q57105513-67A51545-FFDD-4C76-BC8B-D7F527B0F3DFQ58793639-B22B15DC-BBE9-47CE-9E7F-0ADA77D5354FQ59136248-769E657D-1E15-42E7-A61E-C42818E2EC2E
P2860
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@ast
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@en
type
label
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@ast
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@en
prefLabel
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@ast
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@en
P2093
P2860
P1433
P1476
Aberrant KDM5B expression prom ...... downregulation of hsa-miR-448
@en
P2093
Alexander Wu
Chi-Tai Yeh
Liang Shun Wang
Tsu-Yi Chao
Wei-Hwa Lee
Wen-Chien Huang
P2860
P2888
P356
10.1186/S12885-016-2108-5
P407
P577
2016-02-25T00:00:00Z
P5875
P6179
1026818269